Factor IX
Showing 26 - 50 of >10,000
Hemophilia A With Inhibitors, Hemophilia B With Inhibitors Trial in Worldwide (Coagulation FVIIa (Recombinant))
Completed
- Hemophilia A With Inhibitors
- Hemophilia B With Inhibitors
- Coagulation FVIIa (Recombinant)
-
Aurora, Colorado
- +8 more
Feb 24, 2022
Severe Hemophilia B Trial in Worldwide (Factor IX (rFIXFc), rFIX)
Drawn From Central Venous Lines and Venipuncture
Terminated
- Hemophilia A
- +4 more
- Peripheral Vein Blood draw
-
Kansas City, MissouriChildren's Mercy Hospital
Jan 5, 2021
Fc factOrs and Real-World hemophiliA Patient-ReporteD Outcomes
Terminated
- Hemophilia A
- Hemophilia B
- rFVIIIFc
- +3 more
-
Los Angeles, California
- +1 more
Dec 16, 2020
Dosage and PD Study of Eftrenonacog-alfa
Unknown status
- Severe Haemophilia B
- Non interventional study
-
Paris, FranceService d'hématologie biologique - Hôpital Cochin
Oct 15, 2020
Service - Hemophilia: Sources of Variability
Enrolling by invitation
- Hemophilia A
- Hemophilia B
- Variability in individual PK
-
Hamilton, Ontario, CanadaMcMaster University
Sep 17, 2021
(Usage Results Study) of RIXUBIS in Adult and Pediatric
Completed
- Hemophilia B
- RIXUBIS
-
Daegu, Korea, Republic of
- +4 more
Apr 30, 2021
Hemophilia B Trial in Worldwide (PF-06838435 (formerly SPK-9001))
Recruiting
- Hemophilia B
- PF-06838435 (formerly SPK-9001)
-
Sacramento, California
- +24 more
Feb 2, 2023
ATHN 2: Factor Switching Study
Completed
- Hemophilia
- Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013
- Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013
-
San Diego, California
- +26 more
Dec 7, 2021
Hemophilia B Trial in Worldwide (Factor IX Concentrate (purified, virus-inactivated))
Completed
- Hemophilia B
- Factor IX Concentrate (purified, virus-inactivated)
-
Corrientes, Argentina
- +17 more
Apr 21, 2021
Patients With End Stage Liver Disease
Not yet recruiting
- Liver Cirrhosis
- +6 more
-
Palo Alto, CaliforniaStanford Hospital
Aug 23, 2023
Prothrombin Complex Factor Deficiency Trial in Austria, Hungary (Prothrombin complex concentrate (coagulation factors IX, II,
Completed
- Prothrombin Complex Factor Deficiency
- Prothrombin complex concentrate (coagulation factors IX, II, VII and X in combination)
-
Feldkirch, Austria
- +5 more
Apr 30, 2021
Hemophilia B Trial in United Kingdom, United States (Gene Transfer, scAAV2/8-LP1-hFIXco)
Active, not recruiting
- Hemophilia B
- Gene Transfer
- scAAV2/8-LP1-hFIXco
-
Stanford, California
- +7 more
Nov 17, 2022
(SPACE) in Hemophilia Patients Currently Treated With ADVATE or
Completed
- Hemophilia A
- Hemophilia B
- ADVATE (Antihemophilic Factor [Recombinant])
- RIXUBIS (Coagulation Factor IX [Recombinant])
-
Los Angeles, California
- +16 more
Mar 16, 2021
Liver Biopsy Following Gene Therapy For Hemophilia
Not yet recruiting
- Hemophilia A
- Hemophilia B
- Liver Biopsy
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jun 27, 2023
Hemophilia B Trial in Worldwide (BAX 326 (Recombinant factor IX))
Completed
- Hemophilia B
- BAX 326 (Recombinant factor IX)
-
Rosario, Argentina
- +41 more
Apr 30, 2021
LTFU for Gene Transfer Subjects With Hemophilia B
Completed
- Hemophilia B
-
Philadelphia, Pennsylvania
- +1 more
May 14, 2020
Hemophilia A, Hemophilia B Trial in Korea, Republic of, South Africa, Taiwan (marstacimab)
Recruiting
- Hemophilia A
- Hemophilia B
-
Seoul, Seoul-teukbyeolsi [seoul], Korea, Republic of
- +3 more
Jan 18, 2023
Joint Health Study
Completed
- Hemophilia B
-
Los Angeles, California
- +4 more
Jun 17, 2022